Pulmonary hypertension (PH) is classified into 5 clinical subgroups: pulmonary arterial
hypertension (PAH), PH due to left-sided heart disease, PH due to chronic lung disease …

Since 1973 the World Symposia on Pulmonary Hypertension (WSPH) proceedings have
summarised the scientific advances and future needs in this field through the efforts of …

Tens of thousands of patients with advanced lung diseases may be eligible to be considered
as potential candidates for lung transplant around the world each year. The timing of referral …

Abstract The Spanish COPD Guidelines (GesEPOC) were first published in 2012, and since
then have undergone a series of updates incorporating new evidence on the diagnosis and …

A revised diagnostic algorithm provides guidelines for the diagnosis of patients with
suspected pulmonary hypertension, both prior to and following referral to expert centres, and …

Centella asiatica is an ethnomedicinal herbaceous species that grows abundantly in tropical
and sub‐tropical regions of China, India, South‐Eastern Asia and Africa. It is a popular …

Background Among patients meeting diagnostic criteria for idiopathic pulmonary arterial
hypertension (IPAH), there is an emerging lung phenotype characterised by a low diffusion …

Background: The presence of emphysema is relatively common in patients with fibrotic
interstitial lung disease. This has been designated combined pulmonary fibrosis and …

Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

Chronic thromboembolic pulmonary hypertension (CTEPH) is a complication of pulmonary
embolism and a major cause of chronic PH leading to right heart failure and death. Lung …